Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
EDGE THERAPEUTICS, INC.
Jurisdiction of Incorporation/Organization
DE
Year of Incorporation/Organization
2009
Item 2 Issuer Principal Place of Business and Contact Information
139 SOUTH STREET, SUITE 102
NEW PROVIDENCE, NJ 07974
Phone Number:
subscription required
Item 3. Related Persons
Name
BRIAN A. LEUTHNER
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
- PROMOTER
Clarification of Response
Item 3. Related Persons
Name
SOL J. BARER
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
KURT CONTI
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JAMES LOUGHLIN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ROBERT LOCH MACDONALD
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
- PROMOTER
Clarification of Response
Item 3. Related Persons
Name
ISAAC BLECH
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
PRIYA JAMBHEKAR
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ALBERT N. MARCHIO II
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
CARL J. SORANNO
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
PHARMACEUTICALS
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
NO REVENUES
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
03/18/2013
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
50000
Item 12. Sales Compensation
Recipient
MAXIM GROUP LLC
Recipient CRD Number
120708
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
405 LEXINGTON AVENUE
NEW YORK, NY 10174
States of Solicitation
- AL
- AZ
- AR
- CA
- CO
- CT
- DE
- DC
- FL
- GA
- HI
- ID
- IL
- IN
- IA
- KS
- KY
- LA
- ME
- MD
- MA
- MI
- MN
- MS
- MO
- MT
- NE
- NV
- NH
- NJ
- NM
- NY
- NC
- ND
- OH
- OK
- OR
- PA
- PR
- RI
- SC
- SD
- TN
- TX
- UT
- VT
- VA
- WA
- WV
- WI
- WY
Item 13. Offering and Sales Amounts
Total Offering Amount
20000000
Total Amount Sold
6673405
Total Remaining to be Sold
13326595
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
52
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
600608.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
A PORTION OF THE PROCEEDS MAY BE USED TO PAY SALARIES OF SOME RELATED PERSONS LISTED IN ITEM 3.
Signature and Submission
Issuer Name
EDGE THERAPEUTICS, INC.
Issuer Signature
/S/ ALBERT N. MARCHIO II
Signer Name
ALBERT N. MARCHIO II
Signer Title
ASSISTANT SECRETARY
Signature Date
03/18/2013